This inventor holds 1 USPTO granted patent and 18 published patent applications. Top assignees: National Cancer Center, Protanbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 1 Years Active: 2026
Title: Siyoung Choi: Innovator in Cancer Therapy
Introduction
Siyoung Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer therapy, particularly through his innovative research and development of chimeric antigen receptors.
Latest Patents
Siyoung Choi holds a patent titled "Chimeric Antigen Receptor Targeting BCMA and Use Thereof." This patent represents a crucial advancement in targeted cancer therapies, specifically for treating multiple myeloma.
Career Highlights
Throughout his career, Siyoung Choi has worked with esteemed organizations such as the National Cancer Center and Protanbio Inc. His work in these institutions has been instrumental in advancing cancer treatment methodologies.
Collaborations
Siyoung Choi has collaborated with notable colleagues, including Sangjin Lee and Hyeonseok Eom. These partnerships have fostered a collaborative environment that enhances innovation in cancer research.
Conclusion
Siyoung Choi's contributions to cancer therapy through his patent and collaborative efforts highlight his role as a key innovator in the field. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile